Asymptomatic immunodeficiency-associated vaccine-derived poliovirus infections in two UK children

被引:6
|
作者
Singanayagam, Anika [1 ,2 ]
Klapsa, Dimitra [3 ]
Burton-Fanning, Shirelle [4 ]
Hand, Julian [1 ]
Wilton, Thomas [3 ]
Stephens, Laura [3 ]
Mate, Ryan [3 ]
Shillitoe, Benjamin [5 ,6 ]
Celma, Cristina [1 ]
Slatter, Mary [5 ,7 ]
Flood, Terry [5 ]
Gopal, Robin [1 ]
Martin, Javier [3 ]
Zambon, Maria [1 ]
机构
[1] UK Hlth Secur Agcy, Polio Reference Serv, London, England
[2] Imperial Coll London, Dept Infect Dis, London, England
[3] Med & Healthcare Prod Regulatory Agcy, Natl Inst Biol Stand andControl, Div Vaccines, Potters Bar, Herts, England
[4] Newcastle Upon Tyne Hosp NHS Fdn Trust, Microbiol & Virol Serv, Newcastle Upon Tyne, Tyne & Wear, England
[5] Great North Childrens Hosp, Paediat Stem Cell Transplant Unit, Newcastle Upon Tyne, Tyne & Wear, England
[6] Sheffield Childrens NHS Fdn Trust, Sheffield, S Yorkshire, England
[7] Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England
关键词
DISORDERS; EXCRETION; WORLDWIDE; DNA; PCR;
D O I
10.1038/s41467-023-39094-0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Increasing detections of vaccine-derived poliovirus (VDPV) globally, including in countries previously declared polio free, is a public health emergency of international concern. Individuals with primary immunodeficiency (PID) can excrete polioviruses for prolonged periods, which could act as a source of cryptic transmission of viruses with potential to cause neurological disease. Here, we report on the detection of immunodeficiency-associated VDPVs (iVDPV) from two asymptomatic male PID children in the UK in 2019. The first child cleared poliovirus with increased doses of intravenous immunoglobulin, the second child following haematopoetic stem cell transplantation. We perform genetic and phenotypic characterisation of the infecting strains, demonstrating intra-host evolution and a neurovirulent phenotype in transgenic mice. Our findings highlight a pressing need to strengthen polio surveillance. Systematic collection of stool from asymptomatic PID patients who are at high risk for poliovirus excretion could improve the ability to detect and contain iVDPVs.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Asymptomatic immunodeficiency-associated vaccine-derived poliovirus infections in two UK children
    Anika Singanayagam
    Dimitra Klapsa
    Shirelle Burton-Fanning
    Julian Hand
    Thomas Wilton
    Laura Stephens
    Ryan Mate
    Benjamin Shillitoe
    Cristina Celma
    Mary Slatter
    Terry Flood
    Robin Gopal
    Javier Martin
    Maria Zambon
    Nature Communications, 14
  • [2] Clearance of Immunodeficiency-associated Vaccine-derived Poliovirus Infection With Pocapavir
    Copelyn, Julie
    Hincks, Jeffrey R.
    Wilmshurst, Jo M.
    Petersen, Wonita
    Howard, Wayne
    Jallow, Sabelle
    Moonsamy, Shelina
    Seakamela, Lerato
    Suchard, Melinda
    Collett, Marc S.
    Eley, Brian
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2020, 39 (05) : 435 - 437
  • [3] Immunodeficiency-associated Vaccine-Derived Poliovirus Type 3 in Infant, South Africa, 2011
    Gumede, Nicksy
    Muthambi, Vongani
    Schoub, Barry D.
    EMERGING INFECTIOUS DISEASES, 2012, 18 (06) : 992 - 994
  • [4] Comprehensive screening for immunodeficiency-associated vaccine-derived poliovirus: an essential oral poliovirus vaccine cessation risk management strategy
    Tebbens, R. J. Duintjer
    Thompson, K. M.
    EPIDEMIOLOGY AND INFECTION, 2017, 145 (02): : 217 - 226
  • [5] New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of data
    Shaghaghi, Mohammadreza
    Soleyman-jahi, Saeed
    Abolhassani, Hassan
    Yazdani, Reza
    Azizi, Gholamreza
    Rezaei, Nima
    Barbouche, Mohamed-Ridha
    McKinlay, Mark A.
    Aghamohammadi, Asghar
    VACCINE, 2018, 36 (13) : 1711 - 1719
  • [6] Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs
    Tebbens, Radboud J. Duintjer
    Pallansch, Mark A.
    Thompson, Kimberly M.
    BMC INFECTIOUS DISEASES, 2015, 15
  • [7] Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs
    Radboud J. Duintjer Tebbens
    Mark A. Pallansch
    Kimberly M. Thompson
    BMC Infectious Diseases, 15
  • [8] Update on Immunodeficiency-Associated Vaccine-Derived Polioviruses - Worldwide, July 2018-December 2019
    Macklin, Grace
    Diop, Ousmane M.
    Humayun, Asghar
    Shahmahmoodi, Shohreh
    El-Sayed, Zeinab A.
    Triki, Henda
    Rey, Gloria
    Avagyan, Tigran
    Grabovac, Varja
    Jorba, Jaume
    Farag, Noha
    Mach, Ondrej
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 69 (28): : 913 - 917
  • [9] Are Circulating Type 2 Vaccine-Derived Polioviruses (VDPVs) Genetically Distinguishable from Immunodeficiency-associated VDPVs?
    Zhao, Kun
    Jorba, Jaume
    Iber, Jane
    Chen, Qi
    Shaw, Jing
    Bullard, Kelley
    Kew, Olen
    Burns, Cara
    2016 IEEE 6TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL ADVANCES IN BIO AND MEDICAL SCIENCES (ICCABS), 2016,
  • [10] Are Circulating Type 2 Vaccine-derived Polioviruses (VDPVs) Genetically Distinguishable from Immunodeficiency-associated VDPVs?
    Zhao, Kun
    Jorba, Jaume
    Shaw, Jing
    Iber, Jane
    Chen, Qi
    Bullard, Kelley
    Kew, Olen M.
    Burns, Cara C.
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2017, 15 : 456 - 462